Drugs / ZEP-3Na
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04307862 | Dec 2019 → Dec 2024 | atopic eczema | Shulov Innovate for Science Ltd. 2012 | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZEP-3Na | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04307862 ↗ |
| Route | Topical | “The ZEP-3Na 0.1% cream will be applied topically twice daily” NCT04307862 ↗ |